This activity is a rebroadcast of a live virtual symposium that was originally broadcast on September 28, 2021 and includes an interactive, decision simulation posttest.
Program Description
Eosinophilic esophagitis (EoE) is a rare, chronic disease that causes inflammation of the esophagus in response to food allergen exposure or substances in the environment. This condition contributes to worsened quality of life for patients due to impaired social function or physical implications such as stricture formation and dysphagia. Goals of treatment for patients with EoE include reducing symptoms and inflammation, maintaining remission, and avoiding complications with nonpharmacologic and pharmacologic treatment options. There are limitations of current EoE treatments, but there are emerging therapies including corticosteroids and biologics that have been evaluated for their efficacy and safety in patients with EoE. Specialty pharmacists can help improve outcomes in patients with EoE by working to integrate these emerging therapies into treatment paradigms when able. This program also features patient case simulations using videos, which will allow participants to practice making real-world decisions in a timely manner and answer questions while reinforcing important counseling tips when managing patients with EoE.
Target Audience: Specialty pharmacists
Type of Activity: Application
Release date: November 22, 2021
Expiration date: January 22, 2022
Time to complete activity: 1.5 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Identify the pathogenesis, clinical presentation, and diagnostic criteria for eosinophilic esophagitis (EoE)
- Examine the data regarding the efficacy and safety of current and emerging therapies targeting the histology and symptomology of EoE
- Determine the burden of EoE and the role pharmacists have in managing progression of the disease and improving quality of life
Erin Hamai Tom, PharmD, APh, MBA, BCACP
Pharmacy Supervisor, Specialty
Department of Pharmacy Services
UC Davis Health System
Sacramento, California
C. Andrew Kistler, MD, PharmD (Medical Writer)
Clinical Instructor
Division of Gastroenterology and Hepatology
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-21-385-L01-P. The activity is available for CE credit through January 22, 2022.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Erin Hamai Tom, PharmD, APh, MBA, BCACP, and C. Andrew Kistler, MD, PharmD, have no relevant financial relationships with commercial interests to disclose.
Pharmacy Times Continuing Education™ Planning Staff— Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Liza Patel, PharmD, RPh; Kelly McCormick; Susan Pordon; Brianna Winters; and Chloe Taccetta
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
Privacy Policy and Terms of Use Information: